Mahamaya Lifesciences Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	165.23	128.12	53.76	37.51	27.23
Depreciation & Amortization	22.42	12.92	9.62	8.46	8.22
Other Amortization	-	5.18	4.45	4.26	1.37
Loss (Gain) From Sale of Assets	0.09	-0.28	-0.18	-0.21	-
Other Operating Activities	106.77	91.42	65.05	37	16.54
Change in Accounts Receivable	-222.97	-201.54	-187.81	-4.22	-26.95
Change in Inventory	-408.45	-491.84	-162.46	-161.46	-59.25
Change in Accounts Payable	93.73	324.1	-44.06	105.02	90.03
Change in Other Net Operating Assets	-52.07	98.86	27.02	-15.12	-35.58
Operating Cash Flow	-295.24	-33.05	-234.6	11.24	21.62
Operating Cash Flow Growth	-	-	-	-47.99%	-
Capital Expenditures	-88.08	-50.44	-15.13	-28.94	-32.69
Sale of Property, Plant & Equipment	1.04	3.66	0.5	0.4	-
Sale (Purchase) of Intangibles	-72.93	-	-	-	-
Other Investing Activities	4.01	2.03	0.84	0.03	0.15
Investing Cash Flow	-155.96	-44.75	-13.79	-28.51	-32.53
Short-Term Debt Issued	352.15	113.29	322.93	-	-
Long-Term Debt Issued	-	-	6.39	2,277	79.95
Total Debt Issued	352.15	113.29	329.32	2,277	79.95
Short-Term Debt Repaid	-	-59.17	-2.91	-	-
Long-Term Debt Repaid	-25.92	-20.03	-23.91	-2,225	-49.91
Total Debt Repaid	-25.92	-79.2	-26.82	-2,225	-49.91
Net Debt Issued (Repaid)	326.23	34.09	302.5	52.07	30.04
Issuance of Common Stock	642.82	137.94	-	-	-
Other Financing Activities	-163.81	-87.36	-57.23	-28.52	-16.27
Financing Cash Flow	805.24	84.67	245.27	23.55	13.77
Miscellaneous Cash Flow Adjustments	-	-	0	-	-
Net Cash Flow	354.04	6.86	-3.12	6.28	2.86
Free Cash Flow	-383.32	-83.49	-249.73	-17.7	-11.07
Free Cash Flow Margin	-11.62%	-3.16%	-15.46%	-1.29%	-1.23%
Free Cash Flow Per Share	-19.32	-4.92	-18.18	-1.29	-0.81
Cash Interest Paid	-	68.08	57.23	28.52	16.27
Cash Income Tax Paid	-	18.6	11.86	10.56	12.07
Levered Free Cash Flow	-569.51	-130.13	-305.05	-39.34	-
Unlevered Free Cash Flow	-518.64	-95.68	-276.27	-22.89	-
Change in Working Capital	-589.76	-270.42	-367.31	-75.78	-31.74

Source: S&P Global Market Intelligence. Standard template. Financial Sources.